Clovis, in need of cash or deals now to stem looming financial challenges, looks to pipeline for ideas

Clovis Oncology needs cash—and fast. And so the company is making an appeal for some sort of deal or additional capital to ensure it can continue beyond February 2023 “as a going concern.”